n.a. (HSP)

0.00
NYSE
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Exchange NYSE
Div & Yield N.A. (N.A)

Ahead Of The Bell: Jobless Claims

Economists expect small increase in jobless claims, new record in continuing claims

Movers Roundup: Hospira, CB Richard Ellis

Movers roundup: Hospira rise continues on cost-cutting plans, CB Richard Ellis leaps

Hospira Continues To Rise On Restructuring Plan

Hospira shares extend gains on plan to cut jobs, restructure bid to reduce costs

Hospira, Carnival, Walt Disney Are Big Movers

Hospira, Carnival, Walt Disney, Blue Nile, H&R Block are among big market movers Tuesday

Warner Chilcott Sues Impax Over Acne Drug Doryx

Warner Chilcott says it sued Impax over generic 150 mg Doryx, triggering stay of FDA ruling

Warner Chilcott Denied Stay On 2 Doryx Doses

Warner Chilcott Denied Stay On 2 Doryx Doses

Warner Chilcott says FDA won't delay rulings on 2 strengths of Doryx, but may halt a third

Warner Chilcott Faces New Patent Dispute

Warner Chilcott faces new patent dispute over Doryx with Impax Laboratories

NEW: Insider Action -- Who's Buying, Selling

Jonathan Moreland, author of Insider Insights, gives you the lowdown on top stock purchases and sales.

Cramer's 'Mad Money' Recap: July 10

Cramer's 'Mad Money' Recap: July 10

Cramer thinks highly of Hospira, which makes generic drugs that are ready to use in disposable syringes.

Thursday's Analysts' Upgrades, Downgrades

Thursday's Analysts' Upgrades, Downgrades

See who made what calls.

'Fast Money Pops and Drops': Fluor Power

'Fast Money Pops and Drops': Fluor Power

The crew's Guy Adami likes the company's big order backlog.

Stock Upgrades, Downgrades From TheStreet.com Ratings

Hospira, James Hardie upgraded; Sunoco, Coach, Centex downgraded.

After the Fall

Bernanke helps stocks mount a tepid recover. Eaton Vance's Duncan Richardson says opportunity calls.

Hospira in Erythropoietin Pact

It and two other companies will help develop a biosimilar version.

Hospira Sinks on Revenue Miss

Hospira Sinks on Revenue Miss

Shares slide 9%.

Hospira Adds Hale to Board

The move expands the number of directors to nine.

Hospira Inks Agreement With Premier

Hospira Inks Agreement With Premier

The hospital group's members will get access to pain-management systems.

Philly Fed Sinks Stocks

Philly Fed Sinks Stocks

Wall Street tumbles after the report is weaker than expected.

Thursday's Health Winners & Losers

Thursday's Health Winners & Losers

Medivation climbs more than 30%.

Hospira Buying Mayne Pharma

Hospira Buying Mayne Pharma

The price is $2 billion.

Bulls Bid for More Gains

Bulls Bid for More Gains

Futures are pointing to a continued rally on Wall Street Thursday.

Hospira Names Finance Chief

Thomas Werner will join Monday.

Wednesday's Health Winners & Losers

Wednesday's Health Winners & Losers

Allion Healthcare plunges 40%.

Today's Health Winners and Losers

Today's Health Winners and Losers

Syneron Medical slides after earnings miss forecasts.

Hospira Surges on Strong Guidance

Hospira Surges on Strong Guidance

Full-year earnings views top targets.

Today's Health Winners and Losers

Today's Health Winners and Losers

Hospira and King Pharmaceuticals tank after their earnings miss forecasts.

Hospira Plunges on Shortfall

Earnings fall 46% from a year ago, sending the stock down 17%.

Hospira to Expand Plant

The company will sink $60 million into the Kansas facility.

Hospira Plans to Shut Plants

It sees charges.

Health Stocks in Motion

Health Stocks in Motion

Pain Therapeutics jumps on King alliance, while Eyetech drops on concerns over its deal with OSI.